UBS Group AG - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 35 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$12,000
-47.8%
21,849
+87.8%
0.00%
Q2 2021$23,000
+27.8%
11,635
+109.3%
0.00%
Q1 2021$18,000
-25.0%
5,559
-6.8%
0.00%
Q4 2020$24,000
+4.3%
5,963
-21.5%
0.00%
Q2 2020$23,000
-20.7%
7,601
-48.1%
0.00%
Q1 2020$29,000
-88.1%
14,641
-55.6%
0.00%
Q4 2019$243,000
+291.9%
32,948
+140.1%
0.00%
Q3 2019$62,000
+313.3%
13,725
+973.1%
0.00%
Q4 2018$15,000
-85.8%
1,279
-79.5%
0.00%
Q3 2018$106,000
+146.5%
6,224
+148.3%
0.00%
Q2 2018$43,0002,5070.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,950,949$1,092,0000.45%
AMERICAN FINANCIAL GROUP INC 1,480,000$829,0000.25%
Vanguard Capital Wealth Advisors 158,900$86,0000.06%
Atom Investors LP 113,151$63,0000.03%
Nantahala Capital Management 774,767$434,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,173,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$659,0000.01%
Altshuler Shaham Ltd 1,088,848$609,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 309,400$173,0000.00%
Clal Insurance Enterprises Holdings Ltd 585,000$328,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders